Drug
Idp 126
Idp 126: highest development phase Phase 3, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| IDP-126 Gel NCT04214639 | Phase 3 | Acne Vulgaris |
Latest
No recent events.
Follow Idp 126 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.